Galanin Antibody (581403) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB5854JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-reported, Immunohistochemistry, Intracellular Staining by Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # 581403
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E.coli-derived recombinant human Galanin
Ala20-Ser123
Accession # P22466
Ala20-Ser123
Accession # P22466
Specificity
Detects human Galanin in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Galanin Antibody (581403) [Janelia Fluor® 669]
Application
Recommended Usage
CyTOF-reported
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Intracellular Staining by Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Galanin
Alternate Names
GAL, GALN
Gene Symbol
GAL
Additional Galanin Products
Product Documents for Galanin Antibody (581403) [Janelia Fluor® 669]
Product Specific Notices for Galanin Antibody (581403) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...